News
News Center
2020-12-22
Jiuzhitang, leveraging its strong brand leadership, proudly secured a spot on both the "2020 Time-Honored Chinese Medicine Brand List" and the "Top 10 Traditional Chinese Medicine Enterprises" rankings. Meanwhile, Jiuzhitang's two flagship products—Shuxuetong Injection and Liuwei Dihuang Wan—each generating over 100 million yuan in sales, were recognized on the "Clinical-Value-Oriented Traditional Chinese Medicine Brand List"!
+
2020-12-15
As research into the disease mechanisms of stem cell therapy progresses, stem cells have demonstrated promising therapeutic effects across a wide range of medical conditions. Currently, they are already being used to treat more than 200 challenging and complex diseases, offering newfound hope to patients struggling with rare illnesses. Looking ahead, with the continued advancement of regenerative medicine, the clinical translation and implementation of stem cell therapies for diabetes and its associated complications are expected to become a reality sooner rather than later.
+
2020-12-14
CCTV: Stem cell technology helps the "Noodle Brothers" stand tall again.
Twins were diagnosed with the same rare disease, dubbed "Noodle Men," medically known as "Super Cancer," which left them paralyzed at age twelve and ultimately claimed their lives by age eighteen. Their parents embarked on a grueling journey across China, tirelessly searching for a life-saving cure. Thanks to groundbreaking stem-cell therapy, the brothers are now able to walk normally again—giving them a renewed chance at life.
+
2020-12-14
Shenzhen TV and Yishenzen client reporters have just learned from the Standing Committee of the Shenzhen Municipal People's Congress that Shenzhen will take the lead nationwide in enacting legislation to regulate cell and gene therapies!
+
2020-12-08
Jiuzhitang Maker invited to attend the 2nd China Anti-Aging Conference
During the keynote forum's interactive interview session, Dr. Gao Yansong, Vice President of Jiuzhi堂 Group and General Manager of Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. (hereinafter referred to as Jiuzhitang Maker), delivered a keynote speech titled "Exploring Stem Cell Therapy for COVID-19," sharing with the audience how the century-old Jiuzhi堂 has been actively contributing to the fight against the pandemic.
+
2020-12-01
World AIDS Day | The Complete Process of Stem Cell Therapy for HIV/AIDS
When AIDS is mentioned, many people feel panicked—and some even associate it directly with death. In recent years, the groundbreaking cases of "the Berlin Patient" and "the London Patient," both cured of HIV through stem cell therapy, have captured global attention, offering new hope to AIDS patients while also providing valuable lessons and guidance for future clinical applications of similar treatments. Today, let’s explore together how stem cells are being used to treat HIV/AIDS.
+
2020-11-16
World Diabetes Day | @Diabetes Patients, Confidential Documents Are Ready for Your Review!
Today is World Diabetes Day—let’s talk about diabetes, the flagship "wealth disease."
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy